Panel Discussion: Driving Actionable Steps Towards Clinical Trial Diversity Through Harnessing Equity, Diversity & Inclusion (ED&I) to Ensure Precision Medicine is a Fit-for-All
Time: 10:10 am
day: Day 1 AM 2
Details:
- Addressing the under-representation of the world’s population in genomic datasets available to pharmaceutical companies and clinicians
- Illustrating the importance of implementing ED&I in CDx design to facilitate more accurate clinical decisions
- Establishing regulatory frameworks and guidelines to advocate for the wide-spread ED&I in biomarker discovery, clinical biomarker development and CDx development and ensure precision medicine is a fit-for-all
